EUVIMEDEUVIMED entdecken
Kommentar

New ideas about mechanism in APOL1 kidney disease

David J Friedman, Martin R Pollak

Kidney International · 2026-09 · 110 (3) · 519-521

DOI: 10.1016/j.kint.2026.05.021 ↗

Kurz gefasst

Kommentar in der Zeitschrift Kidney International, 2026-09. Verfasst von David J Friedman und 1 weiteren Autor:innen. Beteiligte Einrichtung: Renal Division, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA; Broad Institute…. Hauptthemen laut MEDLINE: Kidney Diseases, Apolipoproteins, Lipoproteins, HDL, Kidney. Die Arbeit nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Apolipoprotein L1 risk variants contribute to high rates of kidney disease among individuals of African ancestry. These gain-of-function variants cause toxicity to kidney cells, but the mechanism of injury is not clear. Many theories have been proposed, yet the field has not arrived at a consensus. Kim et al. make a compelling argument for a peroxisomal pathway of injury specifically activated under hypoxic conditions. Introducing cellular context reframes the debate about apolipoprotein L1 mechanism of disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney DiseasesApolipoproteinsLipoproteins, HDLKidneyHumansApolipoprotein L1Genetic Predisposition to DiseasePeroxisomesAnimals

Substanzen

Apolipoprotein L1APOL1 protein, humanApolipoproteinsLipoproteins, HDL

Autor:innen und Institutionen

  • Renal Division, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA; Broad Institute, Cambridge, Massachusetts, USA. Electronic address: dfriedma@bidmc.ha…
  • Renal Division, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA; Broad Institute, Cambridge, Massachusetts, USA.

Zitieren

APA

Friedman, D. J., & Pollak, M. R. (2026). New ideas about mechanism in APOL1 kidney disease. Kidney International, 110(3), 519-521. https://doi.org/10.1016/j.kint.2026.05.021

Vancouver

Friedman DJ, Pollak MR. New ideas about mechanism in APOL1 kidney disease. Kidney International. 2026;110(3):519-521. doi:10.1016/j.kint.2026.05.021

BibTeX
@article{Friedman2026,
  author = {Friedman, David J and Pollak, Martin R},
  title = {New ideas about mechanism in APOL1 kidney disease},
  journal = {Kidney International},
  year = {2026},
  volume = {110},
  number = {3},
  pages = {519--521},
  doi = {10.1016/j.kint.2026.05.021}
}
Kostenlos starten →